Primary Site >> Colorectal Cancer
Gene >> CXCL9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. PMID: 11731434 |
Ref: HGF and ligation of alphavbeta5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering. PMID: 14697335 Ref: Nitric oxide differentially regulates pro- and anti-angiogenic markers in DLD-1 colon carcinoma cells. PMID: 15063730 Ref: Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. PMID: 15161629 |
Ref: Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. PMID: 16672984 |
Ref: Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy. PMID: 18697200 |
Ref: Expression of chemokines and chemokine receptors in human colon cancer. PMID: 19446722 |
Ref: Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. PMID: 19909745 Ref: Anticancer properties of the IL-12 family--focus on colorectal cancer. PMID: 20712574 |
Ref: Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. PMID: 21859567 |
Ref: A review of mammalian toxicity of ZnO nanoparticles. PMID: 24198497 |
Ref: IFNalpha converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets. PMID: 23153456 Ref: Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. PMID: 23868006 |
Ref: Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2. PMID: 24296981 Ref: Expression profiles of 507 proteins from a biotin label-based antibody array in human colorectal cancer. PMID: 24366523 Ref: Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. PMID: 25101223 Ref: Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. PMID: 25218594 |
Ref: Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors. PMID: 25754875 Ref: Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma. PMID: 25818600 Ref: Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial. PMID: 25970543 Ref: An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. PMID: 26359356 |
Ref: PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. PMID: 26567139 Ref: Ectopic expression of the chemokine CXCL17 in colon cancer cells. PMID: 26889977 Ref: The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients. PMID: 26898419 Ref: Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation. PMID: 26951793 Ref: Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. PMID: 27070705 |
Ref: Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer. PMID: 29163806 |
Ref: Gut microbiota modulate T cell trafficking into human colorectal cancer. PMID: 29437871 Ref: Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer. PMID: 29456737 Ref: Differential role of CXCR3 in inflammation and colorectal cancer. PMID: 29707158 Ref: Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. PMID: 30202097 |